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What’s already known about this topic? 
 Incontinence-associated dermatitis (IAD) is an irritant contact dermatitis in incontinent adults.  
 Ten IAD severity categorisation instruments were developed of which some were found to be 
time-consuming and (linguistically) complex for use in clinical practice. 
 A universal IAD classification system is needed to guide practice, inform educational 
platforms, and support research. 
 
What does this study add? 
 The GLOBIAD is based on input from international experts and was psychometrically tested 
by 823 health professionals from 30 countries. 
 Accuracy of the diagnosis erythema versus skin loss was high when IAD is classified based on 
images.  
 Identifying clinical signs of infection is prone to error. 
 
Summary 
Background Incontinence-associated dermatitis (IAD) is a specific type of irritant contact dermatitis 
with different levels of severity. An internationally accepted instrument to assess the severity of IAD 
in adults with established diagnostic accuracy, agreement, and reliability is needed to support clinical 
practice and research. 
Objectives To design and psychometrically evaluate the Ghent Global IAD Categorisation Tool 
(GLOBIAD). 
Methods The design was based on expert consultation using a three-round Delphi procedure with 34 
experts from 13 countries. The instrument was tested using IAD photographs reflecting different 
severity levels in a sample of 823 health professionals in 30 countries. Measures for diagnostic 
accuracy (sensitivity and specificity), agreement, inter-rater reliability (multi-rater Fleiss kappa), and 
intra-rater reliability (Cohen’s Kappa) were assessed. 
Results The GLOBIAD consists of two categories according to the presence of persistent redness 
(Cat.1) and skin loss (Cat.2), both subdivided based on the presence of clinical signs of infection. The 
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0.87], with a sensitivity of 90% and a specificity of 84%. The overall agreement was 0.55 (95%CI 
0.55-0.56). The Fleiss Kappa for differentiating between Cat.1 and Cat.2 was 0.65 (95%CI 0.65-0.65). 
The overall Fleiss Kappa was 0.41 (95%CI 0.41-0.41). The Cohen’s Kappa for differentiating between 
Cat.1 and Cat.2 was 0.76 (95%CI 0.75-0.77). The overall Cohen’s Kappa was 0.61 (95%CI 0.59-
0.62). 
Conclusions The development of the GLOBIAD is a major step forward towards a better systematic 
assessment of IAD in clinical practice and research worldwide. Further validation is however needed. 
 
INTRODUCTION  
The prevention and treatment of diaper dermatitis in babies and small infants has been recognised for 
decades as a topic of dermatological research and practice1. This cutaneous problem not only occurs in 
paediatric patients but is also common in adults that is widely accepted as incontinence-associated 
dermatitis (IAD)2. IAD is a specific type of irritant contact dermatitis caused by prolonged contact of 
the skin to urine or faeces, and characterised by erythema and oedema of the perianal or genital skin. 
In some cases, the clinical picture is accompanied by bullae, erosion or secondary cutaneous 
infection3. The aetiology of IAD is complex and multifactorial4. Excessive skin surface moisture 
resulting in skin maceration, chemical and physical irritation increases the skin surface pH and 
enhances the permeability of the skin compromising the skin barrier function5. Therefore, the skin is 
more permeable to irritants and pathogens6. The most common microorganisms associated with IAD 
are Escherichia coli and Clostridium difficile from the gastrointestinal tract, Candida albicans, 
Pseudomonas aeruginosa, and Staphylococcus aureus from the perineal skin3-5,7.  
 
The epidemiology of IAD varies across different countries, health care settings and patient 
populations. The prevalence of IAD is estimated between 5.7 and 27% with the highest in acute care 
settings, and the incidence of IAD between 3.4 and 50%3,8. While certain patient populations may be 
more vulnerable to IAD, wide variations in the prevalence of IAD could be explained by the lack of 
internationally agreed diagnostic criteria to differentiate IAD from other skin conditions such as 
superficial pressure ulcers9. In line with the National Pressure Ulcer Advisory Panel (NPUAP) and 
European Pressure Ulcer Advisory Panel (EPUAP) pressure ulcer classification system, the systematic 
assessment of IAD using a valid and reliable international classification tool is recommened9.  
 
A recent Cochrane review revealed a substantial heterogeneity of reported outcomes and instruments 
in IAD research10. To date, ten IAD-related instruments have been developed11-20 of which three were 
developed for IAD risk assessment14,19,20, nine for describing the severity of IAD11-13,15-20, and two 
instruments for the classification and treatment of IAD18,19. Five instruments propose global 
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(cumulative) scoring system to delineate the severity or risk on a continuum or dimension11,13-16. Four 
instruments assess patient-specific symptoms such as pain and burning11,12,19,20. An ideal instrument 
should measure IAD consistently and accurately
21
. Content validity was only assessed in four 
instruments using experts 14-16,20. Psychometric properties of five instruments were tested through the 
assessment of patients14,22 or photographs15,16,23. In addition, several instruments11,13,17 were found to be 
time-consuming and complex for use in clinical practice24.  
 
Therefore, in 2015 an international expert panel proposed a simplified IAD severity categorisation 
tool25. It included three categories: no redness and skin intact (at risk, category 0), red but skin intact 
(category 1), and red with skin breakdown (signs can include vesicles, denudation and/or skin 
infection) (category 2)25. However, this classification was not developed in a formal way and its 
psychometric properties have not been tested. The aim of this study was to further develop this tool 
and to evaluate its psychometric properties. 
 
METHODS  
A two-phase psychometric instrument development and validation study was conducted. Phase 1 
included the design and content validation, phase 2 included the evaluation of the psychometric 
properties of the instrument. 
 
Phase 1. Instrument design and content validation  
The initial version of the simplified tool was used for content validation. To achieve consensus on the 
content validity of the tool, the Delphi method was used to allow a panel of experts to provide 
feedback on the tool and present arguments in order to justify their viewpoints. The panel consisted of 
34 experts from different fields of IAD expertise (clinical n=17; research n=21; education n=11) from 
Australia (n=2), Austria (n=4), Belgium (n=4), Czech Republic (n=1), France (n=1), Germany (n=1), 
Norway (n=1), Italy (n=2), South Africa (n=1), Spain (n=13), Turkey (n=1), United Kingdom (UK; 
n=2), and the United States (US; n=1). In the first round, the expert panel was invited by e-mail 
including the link to an online survey (software package LimeSurvey®). The experts were asked if 
they agree with and had any comments on the proposed purpose, the structure (e.g. number of items), 
and the categories of the tool. Next, the experts were asked if they had any comments concerning the 
definitions and the proposed diagnostic criteria of the three categories and if they had any additional 
comments. After the first round, the results were summarised and presented to the participants. In the 
second and third rounds, the participants were asked if they agreed with and had any comments on the 
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Phase 2. Evaluation of psychometric properties 
The aim was to examine diagnostic accuracy, inter-rater and intra-rater reliability and agreement of the 
instrument. Thirty-four photographs were selected by two experts in IAD diagnostics, who have 
extensive expertise in research and clinical practice (DB & SS). An online survey was developed 
(software package LimeSurvey®) and translated into 14 languages of the 30 participating countries by 
native speakers with extensive content expertise. Back-translation was not performed. The survey 
included information on the procedure and confidentiality, demographic questions, the tool, and the 
photographs. Diagnostic accuracy was measured by comparing the ratings of the participants with 
those of the two experts (reference standard). Inter-rater reliability and agreement was examined 
within the ratings of the participants. Intra-rater reliability and agreement with one week interval 
between ratings was examined for all participants.  
 
Participants 
An online survey was set-up between January and March 2017 in a convenience sample of health 
professionals. Participants were recruited in Australia, Austria, Belgium, Canada, Croatia, Czech 
Republic, Denmark, France, Germany, Hungary, Italy, Norway, Portugal, Saudi Arabia, Slovakia, 
Spain, the Netherlands, Turkey, UK, and the US. The call to participate, including the link to the 
online survey, was sent by e-mail to the EPUAP, NPUAP, the European Wound Management 
Association, the Pan Pacific Pressure Injury Alliance (representing Wounds Australia, New Zealand 
Wound Care Society, Hong Kong Enterostomal Therapist Society, and Wound Healing Society 
Singapore), the Wound, Ostomy and Continence Nurses Society, Wounds Canada, the Canadian 
Association for Enterostomal Therapy, and the Wound Healing Association of Southern Africa. The 




Thirty-four photographs of IAD were selected and categorised by two experts in IAD diagnostics 
(Table S1; see Supporting Information). This set of photographs included two photographs from 
patients with a darkly pigmented skin. The sample size calculation was performed in the statistical 
software package R26 using the function CI4Cats in the kappaSize R-library (version 1.1)27,28 to 
determine the number of photographs needed to study the inter-rater reliability with four outcome 
categories. The confidence interval (CI) approach was used to estimate the sample size for kappa 
calculation (ĸ). A minimum of 33 photographs was required, based on an anticipated value of ĸ of 0.8 
(based on previous research29), an expected lower bound for a one-sided 95% CI of 0.7, and the 
prevalence rates per category (cat. 1A=25%, cat. 1B=15%, cat. 2A=30%, cat. 2B=30% – the estimated 
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Ethical considerations 
The procedure was approved by the ethics committee of Ghent University Hospital (B670201627633). 
All participants received full information before the start of the study. In the questionnaires, the 
purpose and procedure were fully explained, and anonymity and confidentiality were assured. Return 
of a completed questionnaire was taken as consent to participate.  
 
Data analysis 
Diagnostic accuracy, agreement and reliability were calculated. The primary outcome measure was the 
four category classification of the 34 photographs according to the Ghent Global IAD Categorisation 
tool (GLOBIAD) based on persistent redness, skin loss and clinical signs of infection. As secondary 
outcome measures, two binary measures are considered: first, the classification for persistent redness 
or skin loss, second, the classification for with or without clinical signs of infection.  
Summary measures of overall and specific agreement for all levels of the outcome measures were 
calculated. The summary measures were the estimated mean with 95% CI, the estimated median value 
and the interquartile range (IQR), and the 2,5th and 97,5th percentile of the characteristic, based on the 
evaluations of the individual raters to the reference standard. The diagnostic accuracy for secondary 
outcome measures were assessed by summary measures for sensitivity and specificity of each rater to 
the reference standard.  
The inter-rater reliability and agreement among raters was assessed by Fleiss kappa for multiple 
raters30. The scores of the reference standard were not included in the multi-rater Fleiss kappa. The 
intra-rater reliability and agreement were examined by comparing the first and second rating of the 
same photographs for participants who participated twice within one week. No feedback was provided 
between the test and re-rest. The photographs were presented in a random order to reduce potential 
bias. Summary measures of Cohen’s kappa, overall and specific agreement for all levels of the 
outcome measures were calculated for each individual rater.  
The criteria for the ĸ coefficient by Landis & Koch were used to interpret the results (<0.00=Poor, 
0.00–0.2=Slight, 0.21–0.40=Fair, 0.41–0.60=Moderate, 0.61–0.80=Substantial, and 0.81–0.99=Almost 
perfect)31. All measures were calculated in R, version 3.4.126. The concordance function in the R-
library raters, version 2.0.1, was used to obtain Fleiss kappa and 95% CIs, and the kappa2 function in 
the irr (inter-rater reliability and agreement) R-library, version 0.84, for the Cohen’s kappa. 
 
RESULTS 
Instrument design and content validation 
The tool that emerged after the third Delphi round can be found in Figure S1 (see Supporting 
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A first point of discussion was the purpose of the instrument. Several experts emphasised the need for 
a simplified and clear tool to classify IAD. The two-fold purpose of the instrument was approved after 
the second Delphi round. During the Delphi procedure, different items were added to the categories 
(such as a range of clinical signs of infection). A number of items were incorporated in a glossary of 
terms to enhance clarity. These terms were defined according to the terminology of the International 
League of Dermatological Societies and approved in the third Delphi round32. The addition of pain, as 
one of the signs of inflammation, and other patient symptoms emerged as very important for the 
experts to be included in each category. A final point of discussion was the in- or exclusion of 
category 0 describing patients with intact skin but at risk. After the second Delphi round, it was 
decided to delete category 0 to be in line with the existing disease classifications in medicine. The 
absence of a condition is rarely classified and would cause difficulties during psychometric evaluation. 
The GLOBIAD consists of two main categories: (1) persistent redness and (2) skin loss. Each category 
is subdivided into IAD (A) without and (B) with clinical signs of infection. Next to these critical 
criteria, additional criteria are given. Each category is visualised with characteristic images. Category 
1A is displayed in Figure 2. 
 
General characteristics of the participants 
A total of 823 participants (84.6% female) completed the first step and 463 completed the second step 
(Table 1). More detailed information about the country of work of the participants can be found in 
Table S1 (see Supporting Information). 
 
Diagnostic accuracy and agreement 
The diagnostic accuracy and agreement between participants and the reference standard is presented in 
Table 2. The average overall agreement ranged from 0.55 (95% CI 0.55-0.56) for all categories to 0.64 
(95% CI 0.64-0.65) for differentiating between categories A and B, to 0.86 (95% CI 0.86-0.87) for 
differentiating between categories 1 and 2. The lowest mean specific agreement was found for 
categories 1B and 2B (respectively 0.47 (95% CI 0.45-0.48) and 0.47 (95% CI 0.46-0.48)). The 
highest mean specific agreement was found for category 1A (0.72; 95% CI 0.71-0.73). A mean 
sensitivity of 90% (95% CI 0.89-0.91) and a mean specificity of 84% (95% CI 0.83-0.85) was found 
for categorising 1 and 2. Sensitivity and specificity categorising A and B was much lower. A higher 
overall agreement was found in participants who described themselves as expert, ranging from 0.61 
for all categories to 0.70 for differentiating between categories A and B, to 0.88 for differentiating 
categories 1 from 2. 
 
Inter- and intra-rater reliability 
The Fleiss Kappa ranged between 0.32 (95% CI 0.32-0.32) for distinguishing categories A and B, 0.41 
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Higher Fleiss Kappa coefficients were found in more experienced and more educated clinicians. 
Thirty-four photographs were re-assessed by 463 participants with an average time interval of 14 (SD 
8.12) days (Table 4). The average overall intra-rater agreement was 0.71 (95% CI 0.70-0.72), and the 
mean kappa assessing intra-rater reliability was 0.61 (95% CI 0.59-0.62). The intra-rater agreement for 
differentiating between categories 1 and 2 was 0.88 (95% CI 0.88-0.89) and for the intra-rater 
reliability, the mean kappa was 0.76 (95% CI 0.75-0.77). Intra-rater agreement and reliability was 
lower for differentiating between categories A and B. 
 
DISCUSSION 
IAD is highly prevalent among individuals with urinary and/or faecal incontinence3. The heterogeneity 
of reported outcomes and instruments point towards a need for standardised classification10. The aim 
of this study was the design and evaluation of the psychometric properties of the GLOBIAD with the 
input from a group of international experts and clinicians to create an internationally agreed 
description of IAD, and to standardise the documentation for clinical practice and research.  
 
Content and face validity of the GLOBIAD were supported by international expert review and input. 
The key diagnostic criteria for IAD are persistent redness, skin loss, and clinical signs of infection. 
The agreement among experts after Delphi process was 100%. IAD is classified as persistent redness 
or skin loss, two of the most distinguishing features of IAD according to the opinions of 34 
international experts. The clinical presentation of skin loss and erythema could be explained by the 
underlying pathophysiology of IAD3-5. The presence of erythema and skin loss is also consistently 
reflected in all available IAD assessment tools11-20. The assessment of clinical signs of infection was 
considered important and clinically relevant by the experts when categorising IAD due to the choice of 
intervention. This is in line with the high prevalence of cutaneous infections (between 19 and 
63%)6,7,33-35. Finally, the aim of the tool does not include risk assessment therefore category 0 was 
deleted. 
 
In this study, diagnostic accuracy and reliability of GLOBIAD were examined in an international 
sample of 823 health professionals. Sensitivity and specificity estimates indicate a high degree of 
diagnostic accuracy for distinguishing between intact but erythematous skin and skin loss when health 
professionals apply this tool based on the presented images. Diagnostic accuracy of assessing clinical 
signs of infection seemed to be more difficult. Local signs indicating an infection include erythema, 
warmth, swelling, purulent exudate, and pain36 of which some cannot be assessed on photographs. 
Since it is difficult to diagnose wound infection based on clinical observation alone, a (semi-
)quantitative swab of the wound could be considered36,37. However, this technique is time-consuming, 
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health professional is crucial in the management of IAD38,39. Inadequate treatment can cause delayed 
wound healing, prolonged hospitalisation, and an increase in costs40. 
 
Results of the inter-rater reliability estimates can be interpreted in a similar direction. Participants were 
more able to distinguish between intact and eroded skin compared to identifying signs of infection. For 
content validity reasons, it was decided to include the clinical signs of infection in the final tool. Intra- 
rater reliability and agreement across all four categories was ‘substantial’ according to the proposed 
interpretation by Landis and Koch. However, they might be too low to be used for individual clinical 
decision making as one may expect an almost perfect agreement when diagnosing the severity of 
IAD41. 
 
The strengths of the study was the sound content and face validation by a large group of international 
stakeholders which will facilitate and contribute to the global dissemination of the tool. This study had 
limitations. The use of photographs provides a two-dimensional perspective only and important 
clinical signs of infection like warmth, swelling, pain, and itching were not detectable. Further 
validation in clinical practice (including patients affected by IAD) and other methods for validity 
testing are required. In addition, it is also well-known that the ‘base rate’ (Table S1; see Supporting 
Information) influences the reliability estimates41. Because the number of images with clinical signs of 
infection were lower (based on an estimated prevalence in clinical practice), sensitivity and specificity, 
and reliability may have been affected. In addition, there were only two images of darkly pigmented 
skin. This may limit the applicability of the results to all skin phototypes. Translations were done by 
native speakers with extensive content experience in the field of IAD but back-translation was not 
performed42. 
 
IAD as well as pressure ulcers are frequently classified incorrectly9,29,43. In this study, a higher inter-
rater agreement and reliability were found in more experienced and higher educated clinicians. Correct 
classification of IAD requires a profound knowledge and clear understanding of the pathophysiology, 
signs and symptoms43. Correct scoring and the reliability of IAD assessment will enhance when 
sufficient and adequate education and training is provided43. The GLOBIAD was developed as a 
simple, easy and time-saving instrument that can easily be implemented by educators24. More research 
is needed to evaluate the reliability of GLOBIAD and to find out whether better classification skills 
would improve IAD prevention and treatment. 
 
In conclusion, the development of GLOBIAD is a major step towards a better systematic assessment 
of IAD in clinical practice and research worldwide. The use of a valid and reliable IAD categorisation 
tool improves clinical decision making and research in IAD. The GLOBIAD is available in 14 
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Clinical signs of infection contain too much measurement error. We would expect differentiation 
between infected and not infected improved with education. Future research will need to show that. 
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Table 1. Characteristics of the participants 
  Step 1   Step 2 
 n 823  463 
 
n %  n % 
Gender   
 
  Female 696 84.6  383 82.7 
Age       
Mean (SD) in years 40.9 12.0  43.0 11.4 
Role   
 
  Student Nurse 63 7.7  28 6.0 
Nurse assistant 53 6.4  15 3.2 
Nurse 327 39.7  172 37.1 
Head nurse 25 3.0  15 3.2 
Nurse specialist 264 32.1  175 37.8 
Educator 37 4.5  22 4.8 
Researcher 15 1.8  12 2.6 
Other 33 4.0  19 4.1 
Missing 5 0.7  5 1.1 
Education   
 
  Undergraduate 228 27.7  117 25.3 
Bachelor's degree 381 46.3  207 44.7 
Master's degree 166 20.2  10 23.5 
Doctoral degree 39 4.7  25 5.4 
Other / unknown 9 1.1  5 1.1 
Expertise in IAD 
a
   
 
  Novice 117 14.2  55 11.9 
Advanced Beginner 147 17.9  61 13.2 
Competent 231 28.1  136 29.4 
Proficient 180 21.9  114 24.6 
Expert 148 18.0  97 21.0 
Wound care module 
b
   
 
  
Completed 368 44.7  227 49 
Language 
d
   
 
  Arabic 5 0.6  0 0.0 
Croatian 14 1.7  9 1.9 
Czech 82 10.0  55 11.9 
Danish / Norwegian 29 3.5  18 3.9 
Dutch 170 20.7  114 24.6 
English 159 19.3  77 16.6 
French 12 1.5  8 1.7 
German 87 10.6  61 13.2 
Hungarian 21 2.6  9 1.9 
Italian 12 1.5  5 1.1 
Portuguese 30 3.7  17 3.7 
Slovak 69 8.4  22 4.8 
Spanish 74 9.0  43 9.3 
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a Expertise in relation to the assessment and management of IAD (based on the 
levels of proficiency defined by Patricia Benner). b Completion of a recognized 
wound care module. c Estimated number of observed IAD in practice (average a 
week). d Language in which the GLOBIAD and the online survey were translated. 
 
 
Table 2. Diagnostic accuracy and agreement with reference standard – 823 raters 
  







Cat. 1A vs 1B vs 2A vs 2B  
po 
a 0.55 (0.55-0.56) 0.56 (0.47-0.62) 0.35-0.74 
pcat.1A 
b  0.72 (0.71-0.73) 0.73 (0.67-0.78) 0.49-0.89 
pcat.1B 
b  0.47 (0.45-0.48) 0.46 (0.33-0.61) 0.00-0.83 
pcat.2A 
b  0.50 (0.48-0.51) 0.50 (0.40-0.61) 0.13-0.77 
pcat.2B 
b  0.47 (0.46-0.48) 0.47 (0.38-0.57) 0.22-0.74 
Cat. 1 vs 2     
po 
a 0.86 (0.86-0.87) 0.88 (0.82-0.91) 0.71-0.97 
pcat.1 
b 0.85 (0.84-0.85) 0.86 (0.81-0.90) 0.69-0.96 
pcat.2 
b 0.88 (0.87-0.88) 0.89 (0.84-0.92) 0.71-0.97 
Sensitivity 0.90 (0.89-0.91) 0.93 (0.86-1.00) 0.64-1.00 
Specificity 0.84 (0.83-0.85) 0.85 (0.80-0.90) 0.60-1.00 
Cat. A vs B     
po 
a 0.64 (0.64-0.65) 0.65 (0.59-0.71) 0.47-0.82 
pcat.A 
b 0.69 (0.68-0.69) 0.69 (0.63-0.75) 0.48-0.85 
pcat.B 
b 0.57 (0.57-0.58) 0.58 (0.48-0.67) 0.33-0.80 
Sensitivity 0.64 (0.64-0.65) 0.67 (0.57-0.71) 0.38-0.86 
Specificity 0.64 (0.63-0.66) 0.62 (0.54-0.77) 0.31-0.92 
Cat. 1A, persistent redness without clinical signs of infection; Cat. 1B, persistent redness with 
clinical signs of infection; Cat. 2A, skin loss without clinical signs of infection; Cat. 2B, skin loss 
with clinical signs of infection; Cat. 1, persistent redness; Cat. 2, skin loss; Cat. A, absence of 
clinical signs of infection; Cat. B, presence of clinical signs of infection; IQR, interquartile range; 
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Table 3. Inter-rater reliability 
 cat. 1A vs 1B vs 
2A vs 2B 
cat. 1 vs 2 cat. A vs B 
 ĸ (95% CI) ĸ (95% CI) ĸ (95% CI) 
Total sample 
n = 823 
0.41 (0.41-0.41) 0.65 (0.65-0.65) 0.32 (0.32-0.32) 
Novice 
n = 117 
0.40 (0.40-0.40) 0.61 (0.61-0.62) 0.32 (0.31-0.32) 
Advanced 
Beginner 
n = 147 
0.41 (0.40-0.41) 0.62 (0.62-0.62) 0.31 (0.31-0.31) 
Competent 
n = 231 
0.41 (0.41-0.41) 0.65 (0.65-0.65) 0.33 (0.32-0.33) 
Proficient 
n = 180 
0.44 (0.43-0.44) 0.68 (0.68-0.69) 0.34 (0.34-0.34) 
Expert 
n = 148 
0.44 (0.43-0.44) 0.68 (0.68-0.69) 0.36 (0.35-0.36) 
Undergraduate 
n = 228 
0.40 (0.40-0.40) 0.63 (0.63-0.64) 0.31 (0.31-0.31) 
Bachelor’ degree 
n = 381 
0.42 (0.41-0.42) 0.65 (0.65-0.65) 0.33 (0.32-0.33) 
Master’ degree 
n = 166 
0.41 (0.41-0.41) 0.66 (0.66-0.67) 0.32 (0.32-0.32) 
Doctoral degree 
n = 39 
0.43 (0.42-0.44) 0.66 (0.65-0.68) 0.33 (0.32-0.35) 
Wound care module   
Not completed 
n = 456 
0.41 (0.41-0.41) 0.63 (0.63-0.63) 0.32 (0.32-0.32) 
Completed  
n = 368 
0.42 (0.42-0.42) 0.68 (0.68-0.68) 0.33 (0.33-0.33) 
Cat. 1A, persistent redness without clinical signs of infection; Cat. 1B, persistent 
redness with clinical signs of infection; Cat. 2A, skin loss without clinical signs of 
infection; Cat. 2B, skin loss with clinical signs of infection; Cat. 1, persistent redness; 
Cat. 2, skin loss; Cat. A, absence of clinical signs of infection; Cat. B, presence of 
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Table 4. Intra-rater reliability and agreement – 463 raters 
  







Cat. 1A vs 1B vs 2A vs 2B  
ĸ a 0.61 (0.59-0.62) 0.60 (0.51-0.71) 0.33-0.84 
po 
b 0.71 (0.70-0.72) 0.71 (0.65-0.79) 0.47-0.88 
pcat.1A 
c  0.77 (0.76-0.78) 0.80 (0.71-0.86) 0.50-0.95 
pcat.1B 
c  0.60 (0.58-0.62) 0.63 (0.46-0.77) 0.00-0.93 
pcat.2A 
c  0.62 (0.60-0.63) 0.63 (0.50-0.74) 0.22-0.91 
pcat.2B 
c  0.74 (0.73-0.75) 0.77 (0.67-0.83) 0.43-0.96 
Cat. 1 vs 2     
ĸ a 0.76 (0.75-0.77) 0.76 (0.69-0.87) 0.47-0.94 
po 
b 0.88 (0.88-0.89) 0.88 (0.85-0.94) 0.74-0.97 
pcat.1 
c 0.87 (0.86-0.87) 0.88 (0.82-0.92) 0.69-0.97 
pcat.2 
c 0.89 (0.88-0.90) 0.90 (0.86-0.94) 0.72-0.98 
Cat. A vs B     
ĸ a 0.56 (0.54-0.58) 0.58 (0.43-0.70) 0.19-0.88 
po 
b 0.79 (0.78-0.79) 0.79 (0.74-0.85) 0.59-0.94 
pcat.A 
c 0.79 (0.78-0.80) 0.80 (0.73-0.86) 0.58-0.94 
pcat.B 
c 0.77 (0.76-0.78) 0.78 (0.71-0.85) 0.52-0.94 
Cat. 1A, persistent redness without clinical signs of infection; Cat. 1B, persistent redness with 
clinical signs of infection; Cat. 2A, skin loss without clinical signs of infection; Cat. 2B, skin loss 
with clinical signs of infection; Cat. 1, persistent redness; Cat. 2, skin loss; Cat. A, absence of 
clinical signs of infection; Cat. B, presence of clinical signs of infection. a ĸ, Cohen’s Kappa 
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